Abstract
The small, chromatin-associated HMGA proteins contain three separate DNA binding domains, so-called AT hooks, which bind preferentially to short AT-rich sequences. These proteins are abundant in pluripotent embryonic stem (ES) cells and most malignant human tumors, but are not detectable in normal somatic cells. They act both as activator and repressor of gene expression, and most likely facilitate DNA architectural changes during formation of specialized nucleoprotein structures at selected promoter regions. For example, HMGA2 is involved in transcriptional activation of certain cell proliferation genes, which likely contributes to its well-established oncogenic potential during tumor formation. However, surprisingly little is known about how HMGA proteins bind DNA packaged in chromatin and how this affects the chromatin structure at a larger scale. Experimental evidence suggests that HMGA2 competes with binding of histone H1 in the chromatin fiber. This could substantially alter chromatin domain structures in ES cells and contribute to the activation of certain transcription networks. HMGA2 also seems capable of recruiting enzymes directly involved in histone modifications to trigger gene expression. Furthermore, it was shown that multiple HMGA2 molecules bind stably to a single nucleosome core particle whose structure is known. How these features of HMGA2 impinge on chromatin organization inside a living cell is unknown. In this commentary, we propose that HMGA2, through the action of three independent DNA binding domains, substantially contributes to the plasticity of ES cell chromatin and is involved in the maintenance of a un-differentiated cell state.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bianchi, M. E., & Agresti, A. (2005). HMG proteins: dynamic players in gene regulation and differentiation. Current Opinion in Genetics & Development., 15, 496–506.
Reeves, R., & Beckerbauer, L. (2001). HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochimica et Biophysica Acta-Gene Structure and Expression, 1519, 13–29.
Chau, K. Y., Patel, U. A., Lee, K. L., Lam, H. Y., & Crane-Robinson, C. (1995). The gene for the human architectural transcription factor HMGI-C consists of five exons each coding for a distinct functional element. Nucleic Acids Research, 23, 4262–4266.
Chieffi, P., Battista, S., Barchi, M., et al. (2002). HMGA1 and HMGA2 protein expression in mouse spermatogenesis. Oncogene, 21, 3644–3650.
Li, O., Vasudevan, D., Davey, C. A., & Droge, P. (2006). High-level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells. Genesis, 44, 523–529.
Li, O., Li, J., & Droge, P. (2007). DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells. FEBS Letters, 581, 3533–3537.
Weedon, M. N., Lango, H., Lindgren, C. M., et al. (2008). Genome-wide association analysis identifies 20 loci that influence adult height. Nature Genetics, 40, 575–583.
Ligon, A. H., Moore, S. D., Parisi, M. A., et al. (2005). Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas. American Journal of Human Genetics, 76, 340–348.
Zhou, X., Benson, K. F., Ashar, H. R., & Chada, K. (1995). Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature, 376, 771–774.
Fedele, M., Fidanza, V., Battista, S., et al. (2006). Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Research, 66, 2536–2543.
Foti, D., Chiefari, E., Fedele, M., et al. (2005). Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nature Medicine, 11, 765–773.
Fusco, A., & Fedele, M. (2007). Roles of HMGA proteins in cancer. Nature Reviews Cancer, 7, 899–910.
Persson, F., Andren, Y., Winnes, M., et al. (2009). High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2. Genes Chromosomes Cancer, 48, 69–82.
Droge, P., & Davey, C. A. (2008). Do cells let-7 determine stemness? Cell Stem Cell, 2, 8–9.
Hammond, S. M., & Sharpless, N. E. (2008). HMGA2, microRNAs, and stem cell aging. Cell, 135, 1013–1016.
Fukada, S. I., Uezumi, A., Ikemoto, M., et al. (2007). Molecular signature of quiescent satellite cells in adult skeletal muscle. Stem Cells, 25, 2448–2459.
Reeves, R., Nissen, M. S., & The, A. (1990). T-Dna-binding domain of mammalian high mobility group-I chromosomal-proteins—a novel peptide motif for recognizing Dna-structure. Journal of Biological Chemistry, 265, 8573–8582.
Manfioletti, G., Rustighi, A., Mantovani, F., Goodwin, G. H., & Giancotti, V. (1995). Isolation and characterization of the gene coding for murine high-mobility-group protein HMGI-C. Gene, 167, 249–253.
Patel, U. A., Bandiera, A., Manfioletti, G., Giancotti, V., Chau, K. Y., & Crane-Robinson, C. (1994). Expression and cDNA cloning of human HMGI-C phosphoprotein. Biochemical and Biophysical Research Communications, 201, 63–70.
Miao, Y., Cui, T., Leng, F., & Wilson, W. D. (2008). Inhibition of high-mobility-group A2 protein binding to DNA by netropsin: a biosensor-surface plasmon resonance assay. Analytical Biochemistry, 374, 7–15.
Huth, J. R., Bewley, C. A., Nissen, M. S., et al. (1997). The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nature Structural Biology, 4, 657–665.
Cui, T. J., Wei, S., Brew, K., & Leng, F. F. (2005). Energetics of binding the mammalian high mobility group protein HMGA2 to poly(dA-dT)(2) and poly(dA)-poly(dT). Journal of Molecular Biology, 352, 629–645.
Levy, W. B., & Dixon, G. H. (1978). A study of the localization of high mobility group proteins in chromatin. Canadian Journal of Biochemistry, 56, 480–491.
Tessari, M. A., Gostissa, M., Altamura, S., et al. (2003). Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2. Molecular and Cellular Biology, 23, 9104–9116.
Fedele, M., Pierantoni, G. M., Visone, R., & Fusco, A. (2006). E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression. Cell Division, 1, 17.
Fedele, M., Visone, R., De Martino, I., et al. (2006). HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell, 9, 459–471.
Di Cello, F., Hillion, J., Hristov, A., et al. (2008). HMGA2 participates in transformation in human lung cancer. Molecular Cancer Research, 6, 743–750.
Borrmann, L., Schwanbeck, R., Heyduk, T., et al. (2003). High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity. Nucleic Acids Research, 31, 6841–6851.
Boo, L. N., Lin, H. H., Chung, V., et al. (2005). High mobility group A2 potentiates genotoxic stress in part through he modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation. Cancer Research, 65, 6622–6630.
Reeves, R., & Wolffe, A. P. (1996). Substrate structure influences binding of the non-histone protein HMG-I(Y) to free and nucleosomal DNA. Biochemistry, 35, 5063–5074.
Reeves, R., & Nissen, M. S. (1993). Interaction of High-Mobility Group-I(Y) Nonhistone Proteins with Nucleosome Core Particles. Journal of Biological Chemistry, 268, 21137–21146.
Goodwin, G. H., Mathew, C. G. P., Wright, C. A., Venkov, C. D., & Johns, E. W. (1979). Analysis of the High Mobility Group Proteins Associated with Salt-Soluble Nucleosomes. Nucleic Acids Research, 7, 1815–1835.
Funayama, R., Saito, M., Tanobe, H., & Ishikawa, F. (2006). Loss of linker histone H1 in cellular senescence. Journal of Cell Biology, 175, 869–880.
Narita, M., Narita, M., Krizhanovsky, V., et al. (2006). A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation. Cell, 126, 503–514.
Catez, F., Yang, H., Tracey, K. J., Reeves, R., Misteli, T., & Bustin, M. (2004). Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Molecular and Cellular Biology, 24, 4321–4328.
Lever, M. A., Th'Ng, J. P. H., Sun, X. J., & Hendzel, M. J. (2000). Rapid exchange of histone H1.1 on chromatin in living human cells. Nature, 408, 873–876.
Misteli, T., Gunjan, A., Hock, R., Bustin, M., & Brown, D. T. (2000). Dynamic binding of histone H1 to chromatin in living cells. Nature, 408, 877–881.
Meshorer, E., Yellajoshula, D., George, E., Scambler, P. J., Brown, D. T., & Misteli, T. (2006). Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell, 10, 105–116.
Phair, R. D., & Misteli, T. (2000). High mobility of proteins in the mammalian cell nucleus. Nature, 404, 604–609.
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 418, 191–195.
Sgarra, R., Furlan, C., Zammitti, S., et al. (2008). Interaction proteomics of the HMGA chromatin architectural factors. Proteomics, 8, 4721–4732.
Sgarra, R., Tessari, M. A., Di Bernardo, J., et al. (2005). Discovering high mobility group A molecular partners in tumour cells. Proteomics, 5, 1494–1506.
Gilbert, N., & Ramsahoye, B. (2005). The relationship between chromatin structure and transcriptional activity in mammalian genomes. Briefings in Functional Genomics and Proteomics, 4, 129–142.
Hock, R., Witte, F., Brocher, J., Schutz, M., & Scheer, U. (2006). Expression of HMGA2 variants during oogenesis and early embryogenesis of Xenopus laevis. European Journal of Cell Biology, 85, 519–528.
Tan, S. M., Wang, S. T., Hentze, H., & Droge, P. (2007). A UTF1-based selection system for stable homogeneously pluripotent human embryonic stem cell cultures. Nucleic Acids Research, 35, e118.
van den Boom, V., Kooistra, S. M., Boesjes, M., et al. (2007). UTF1 is a chromatin-associated protein involved in ES cell differentiation. Journal of Cell Biology, 178, 913–924.
Nishimoto, M., Fukushima, A., Okuda, A., & Muramatsu, M. (1999). The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Molecular and Cellular Biology, 19, 5453–5465.
Funding
This work was supported by a grant of the Stem Cell Network North Rhine Westphalia, Germany (grant No: 314–40000808) and the Ministry of Education, Singapore.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Pfannkuche, K., Summer, H., Li, O. et al. The High Mobility Group Protein HMGA2: A Co-Regulator of Chromatin Structure and Pluripotency in Stem Cells?. Stem Cell Rev and Rep 5, 224–230 (2009). https://doi.org/10.1007/s12015-009-9078-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-009-9078-9